Detecting Occult Proximal Humeral Neck Fractures Through CT and MRI Tests of Patients With Greater Tuberosity Fractures

NCT ID: NCT03481478

Last Updated: 2018-03-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-03-24

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients with greater tuberosity fractures is becoming increasingly common, as is the number of cases of humeral surgical neck fractures. This study investigated the relationship between size of greater tuberosity fragment and occurrence of humeral surgical neck fractures by using CT or MRI tests.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Some humeral surgical neck fractures can be detected through X-ray of shoulder in patients with greater tuberosity fractures. However, some fractures can not be find through conventional X-ray in such patients unless broader CT or MRI tests are required to confirm diagnoses of humeral surgical neck fractures.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Humeral Greater Tuberosity Humeral Fractures/ Proximal Fractures/ Occult

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with greater tuberosity fractures

If humeral surgical neck fractures can be detected through CT or MRI in such groups.

CT and MRI

Intervention Type DIAGNOSTIC_TEST

For such patients, using CT and/or MRI to find if existing humeral surgical neck fractures.

Dislocation patients with greater tuberosity fractures

If humeral surgical neck fractures can be detected through CT or MRI in such groups.

CT and MRI

Intervention Type DIAGNOSTIC_TEST

For such patients, using CT and/or MRI to find if existing humeral surgical neck fractures.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CT and MRI

For such patients, using CT and/or MRI to find if existing humeral surgical neck fractures.

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients 18 years or older with greater tuberosity fractures and shoulder dislocation/ or not who were acute injured were included

Exclusion Criteria

* Patients with ipsilateral previous proximal humeral fractures and obviously proximal humeral fractures were excluded。
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hebei Medical University Third Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Guo Junfei, MD

Role: STUDY_DIRECTOR

Hebei Medical University Third Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hebei Medical University Third Hospital

Shijiazhuang, Hebei, China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hou Zhiyong, MD

Role: CONTACT

+86 18533112800

Guo Junfei, MD

Role: CONTACT

+86 18231181811

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Zhiyong Hou, M.D

Role: primary

+8618533112800

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HZY2018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.